Pedro Cuevas Sanchez,Guillermo Gimenez Gallego,Inigo Saenz De Tejada Morgan,Javier Angulo Frutos,Rosa Maria Lozano Puerto,Antonio Romero Garrido,Serafin Valverde Lopez
申请号：
US13964827
公开号：
US20140206654A1
申请日:
2013.08.12
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention refers to the use of a compound of Formula (I′) or pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the treatment and/or prophylaxis of hematological dyscrasias, including myelodysplastic syndromes (MDSs) and for improving the efficacy of chemotherapy, radiation therapy and/or cancer immunotherapy. In addition, it relates to the use of a compound of formula (I″) for the treatment and/or prophylaxis of cancer of an organ.
